InvestorsHub Logo

marzan

10/07/19 8:05 AM

#217980 RE: sharinky #217979

Agree one million percent! In the midst of all the endorsements coming from all different corners of the world, the generics and DS industries and BPs will have no complaints when the panel and subsequently FDA approves the broadest label, imo. Those even buying the highest strike of call options from January and beyond will still make a ton of money, imo.

Invest83838

10/07/19 8:39 AM

#217985 RE: sharinky #217979

I Sincerely Hope it Ends up Being as Simple as That